Melola Discovery

← Melola Discovery

Jurnal SINTA 1

EFFECT OF G-CSF ON ANC LEVEL IN ALL (Acute Lymphoblastic Leukemia) PATIENT WITH NEUTROPENIA AND FEBRILE NEUTROPENIA DURING CHEMOTHERAPY

Folia Medica Indonesiana · Vol. 50 No. 3 (2014)

ISSN
2355-8393, 2599-056X
Terbit
2014-07-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Acute Lymphoblastic Leukemia (ALL) is the most common malignancy in children. Chemotherapy-induced neutropenia (CIN) is oneof the serious adverse events that may cause complication such as febrile neutropenia. Neutrophils level is increased using G-CSF,whose effectiveness based on ANC (absolute neutrophil counts) pre and post G-CSF therapy level remains unknown. This study wasto analyze the ANC level changes pre and post G-CSF therapy in neutropenia and febrile neutropenia patients with standard risk andhigh risk chemotherapy protocol. This was a retrospective-observational study from January 2010 to December 2013. Pre-therapyANC level had been collected before receiving G-CSF therapy. Post-therapy ANC level was collected between day 1 to 7 aftertherapy discontinuation. Data were analyzed using paired t-test to determine ANC level changes pre- and post-therapy. Range of GCSFdose of neutropenia vs febrile neutropenia patient with SR protocols therapy was 9.172 ± 1.5646 vs 9.079 ± 1.646 μg/kgBW,and for HR protocols 9.909 ± 1.1229 vs 9.114 ± 1.8551 μg/kgBW/day. In conclusion, G-CSF in a dose of 5-10 μg/kgBW per dayincreases ANC level significantly in ALL patients with neutropenia under high risk and standard risk protocol and in ALL patientswith febrile neutropenia under standard risk protocol. However, the increase of ANC level is not significant in ALL patients withfebrile neutropenia under high risk protocol. (FMI 2014;50 179-186)

Kata kunci

Jaringan kolaborasi para penulis

31 penulis · 63 tautan kepenulisan bersama · 18 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Poltekkes Kemenkes Malang
  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • Universitas Pesantren Tinggi Darul Ulum Jombang
  • State University of Semarang
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Yulistiani YulistianiUniversitas Airlangga4
Siti MuafifahState University of Semarang2
Erliyah Nurul JannahUniversitas Pesantren Tinggi Darul Ulum Jombang1
Mukhammad MasrurUniversitas Pesantren Tinggi Darul Ulum Jombang1
Kerent Thania DadhinastitiePoltekkes Kemenkes Malang1
WandiPoltekkes Kemenkes Malang1
Cholifa Arika WardaniPoltekkes Kemenkes Malang1
Handy LalaPoltekkes Kemenkes Malang1
Fiashriel LundyPoltekkes Kemenkes Malang1
Rena Aanisah Dhiyaa' PermataPoltekkes Kemenkes Malang1
Octaviana Maria SimbolonUniversitas Airlangga1
I Dg UgrasenaUniversitas Airlangga1
Nun ZairinaRumah Sakit Dokter Soetomo1
Febriansyah Nur UtomoRumah Sakit Dokter Soetomo1
Mia Ratwita AndarsiniUniversitas Airlangga1
Levana RismayantiUniversitas Airlangga1
Bagus Putu Putra SuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Hendera HenderaAfiliasi tidak diketahui1
Dessy Surya SetyaniUniversitas Airlangga1
Ninik AsmaningsihRumah Sakit Dokter Soetomo1
I Dewa Gede UgrasenaUniversitas Airlangga1
Edy SupriadiAfiliasi tidak diketahui1
Laura VrolingAfiliasi tidak diketahui1
Jacqueline J CloosAfiliasi tidak diketahui1
Muhammad YahyaRumah Sakit Dokter Soetomo1
SuhatnoAfiliasi tidak diketahui1
Elisabeth KasihAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">EFFECT OF G-CSF ON ANC LEVEL IN ALL (Acute Lymphoblastic Leukemia) PATIENT WITH NEUTROPENIA AND FEBRILE NEUTROPENIA DURING CHEMOTHERAPY</dc:title><dc:creator>Siti Asiyah</dc:creator><dc:creator>Bambang Permono</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>Mariyatul Qibtiyah</dc:creator><dc:subject>granulocyte colony-stimulating factor</dc:subject><dc:subject>acute lymphoblastic leukemia</dc:subject><dc:subject>febrile neutropenia</dc:subject><dc:subject>chemotherapy-induced neutropenia</dc:subject><dc:subject>absolute neutrophil count</dc:subject><dc:subject>pediatric leukemia</dc:subject><dc:description xml:lang="en">Acute Lymphoblastic Leukemia (ALL) is the most common malignancy in children. Chemotherapy-induced neutropenia (CIN) is oneof the serious adverse events that may cause complication such as febrile neutropenia. Neutrophils level is increased using G-CSF,whose effectiveness based on ANC (absolute neutrophil counts) pre and post G-CSF therapy level remains unknown. This study wasto analyze the ANC level changes pre and post G-CSF therapy in neutropenia and febrile neutropenia patients with standard risk andhigh risk chemotherapy protocol. This was a retrospective-observational study from January 2010 to December 2013. Pre-therapyANC level had been collected before receiving G-CSF therapy. Post-therapy ANC level was collected between day 1 to 7 aftertherapy discontinuation. Data were analyzed using paired t-test to determine ANC level changes pre- and post-therapy. Range of GCSFdose of neutropenia vs febrile neutropenia patient with SR protocols therapy was 9.172 ± 1.5646 vs 9.079 ± 1.646 μg/kgBW,and for HR protocols 9.909 ± 1.1229 vs 9.114 ± 1.8551 μg/kgBW/day. In conclusion, G-CSF in a dose of 5-10 μg/kgBW per dayincreases ANC level significantly in ALL patients with neutropenia under high risk and standard risk protocol and in ALL patientswith febrile neutropenia under standard risk protocol. However, the increase of ANC level is not significant in ALL patients withfebrile neutropenia under high risk protocol. (FMI 2014;50 179-186)</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2014-07-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/FMI@effect-of-g-csf-on-anc-level-in-all-(acute-lymphoblastic-leukemia)-patient-with-neutropenia-and-febrile-neutropenia-during-chemotherapy-article-9248-media-3-category-3.html</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 50 No 3 (2014)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>